XOMA Royalty Q1 net income $2.4M, total revenues $15.9M; adds Castle Creek royalty, sells Kinnate assets

XOMA Royalty Corp

2025-Q1 EPS reported $0.06 revenue$15,912,000

Q1 2025 total revenues $15.9M (vs $1.5M Q1 2024); net income $2.4M (vs net loss $8.6M).
Cash receipts $18.0M in Q1, including $13.4M royalties and $4.6M milestones; cash $95.0M at March 31.
Acquired Phase 3 royalty interest in Castle Creek's D-Fi (DEB) for $5M; sold all unpartnered Kinnate assets.
Milestone: $4.0M from Day One/Ipsen MAA filing for tovorafenib with EMA; $3.0M net from Takeda Phase 3 start (Q2).
Share repurchases: $0.5M for 25,828 shares; paid $1.4M in preferred dividends.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.